Astra rebuffs 'final' Pfizer bid

US drugs giant Pfizer's attempt to takeover AstraZeneca has come to a dead-end.

US pharmaceutical group Pfizer appears to have lost the battle for Anglo-Swedish rival AstraZeneca. The firm's final offer of £55 per share was rejected by Astra's board as inadequate.

Unless shareholders put pressure on the board to reconsider before the deadline of 26 May, Pfizer will have to wait three months to make a higher offer with Astra's approval, or six months if it wants to mount a hostile bid.

What the commentators said

A bid of £60 might well have tipped the balance, but by tabling a "take-it-or-leave-it" bid and urging Astra's shareholders to revolt, the firm badly miscalculated.

"Pfizer has a risky way back into a deal," said Chris Hughes on Breakingviews.com. It has the right to raise its final price if the offer is accepted, so it could signal to Astra's board that if Astra were to accept £55, Pfizer would immediately significantly increase it.

But the Takeover Panel, which oversees deals in the UK, would not be keen on an attempt to bend the rules and might well block the bid.

So could Pfizer return in six months? Probably not, said Kamal Ahmed on BBC.co.uk. By then, "AstraZeneca shareholders believe the US government will have gone a long way to closing the tax loophole which was one of the reasons for Pfizer being so attracted to AstraZeneca." The bid seems to be dead.

Recommended

Stockmarkets shrug off turbulence
Stockmarkets

Stockmarkets shrug off turbulence

Stockmarkets have hit their first bout of turbulence of the year, but most are clinging onto January’s gains.
4 Feb 2021
AstraZeneca turns the tables as it acquires US pharmaceutical firm Alexion
Biotech stocks

AstraZeneca turns the tables as it acquires US pharmaceutical firm Alexion

AstraZeneca, the British pharma giant, was almost swallowed up by Pfizer a few years ago. Now it has struck a megadeal of its own. Matthew Partridge r…
17 Dec 2020
The great rotation is firmly underway – what does it mean for you?
Stockmarkets

The great rotation is firmly underway – what does it mean for you?

As investors move away from “jam tomorrow” stocks and back into “old economy” stocks that should benefit from the post-pandemic recovery, the tech-hea…
5 Mar 2021
America’s “SPAC” boom is coming to Europe
Stockmarkets

America’s “SPAC” boom is coming to Europe

SPACs are shell firms that list on the stockmarket in order to raise cash, then merge with another company. Once confined to the US tech scene, Europe…
4 Mar 2021

Most Popular

A beginner’s guide to bitcoin: where to store your bitcoins
Bitcoin

A beginner’s guide to bitcoin: where to store your bitcoins

Once you've got hold of some bitcoins, you need somewhere secure to keep them. Dominic Frisby outlines some of the best options, from exchanges to col…
4 Mar 2021
A beginner’s guide to bitcoin: the technical genius behind bitcoin and the blockchain – and how it all works
Bitcoin

A beginner’s guide to bitcoin: the technical genius behind bitcoin and the blockchain – and how it all works

In the second in his series on bitcoin, Dominic Frisby looks at the blockchain – bitcoin’s unique underlying architecture – and what makes it and the …
2 Mar 2021
Why gold has been such a bad investment so far this year
Gold

Why gold has been such a bad investment so far this year

Gold – the ultimate safe haven investment – is proving anything but safe. It’s lost over $200 an ounce since its high at the start of the year. Domini…
3 Mar 2021